China (Mainland)
Molnupiravir CAS NO.2349386-89-4
- FOB Price: USD: 35.00-50.00 /Kilogram Get Latest Price
- Min.Order: 10 Gram
- Payment Terms: L/C,D/P,T/T
- Available Specifications:
gram(10-100)Kilogramgram(100-500)Kilogramkg(1-5)Kilogram
- Product Details
Keywords
- COVID-19
- 99% purity
- in stock
Quick Details
- ProName: Molnupiravir
- CasNo: 2349386-89-4
- Molecular Formula: C13H19N3O7
- Appearance: white to off-white crystalline powder
- Application: COVID-19
- DeliveryTime: in stock
- PackAge: double PE bags+Aluminum foil bags
- Port: Shenzhen/Beijing
- ProductionCapacity: 5 Kilogram/Month
- Purity: 99%
- Storage: in tight container, protected from lig...
- Transportation: FEDEX or by air
- LimitNum: 10 Gram
- Related Substances: ≤0.5%
- Residue on Ignition: ≤0.1%
- Valid Period: two years
- Assay: 98.0%~102.0%
Superiority
We are the first company who has successfully synthetized this API, the newest drug for COVID-19 from MK, MK-4482.
We have 500g material in stock and we have sold to several clients already such as Pakistan and Banladesh.
We can offer MOA, MSDS, TSE/BSE and stability data.
Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
We have already exported to Pakistan and Bangladesh market successfully, hope we can have more cooperation from worldwide clients.
Details
Molnupiravir is an experimental antiviral drug which is orally active and was developed for the treatment of influenza. It is a prodrug of the synthetic nucleoside derivative N4-hydroxycytidine, and exerts its antiviral action through introduction of copying errors during viral RNA replication.
We are the first company who can offer this material in 500g and 1kg quantity, and we can offer MOA, MSDS, TSE/BSE, SDS if client wants to register with local government.
We have already exported to Pakistan and Bangladesh market successfully, hope we can have more cooperation from worldwide clients.
We are the first company who has successfully synthetized this API, the newest drug for COVID-19 from MK, MK-4482.
We have 500g material in stock and we have sold to several clients already such as Pakistan and Banladesh.
We can offer MOA, MSDS, TSE/BSE and stability data.
